Status:

UNKNOWN

Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Lead Sponsor:

Institute of Liver and Biliary Sciences, India

Conditions:

Liver Cirrhosis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Cirrhotic patients with sepsis represent a very sick subset of patients and septic shock in such patients is associated with high mortality. Early initiation of intravenous fluids and antibiotics is t...

Detailed Description

Hypothesis: Combination of 20% albumin with plasmalyte could be better than 5% albumin for fluid resuscitation in critically ill cirrhosis patients due to less incidence of hyperchloremic metabolic ac...

Eligibility Criteria

Inclusion

  • Age - 18-75 yrs of age
  • Cirrhotic patients with sepsis induced hypotension defined as mean arterial pressure less than 65mm of Hg with suspected (as per history and examination) or documented evidence of infection.

Exclusion

  • Patients with other causes of hypotension
  • Patients who have already received bolus of 5% albumin or plasmalyte or \>2L of fluids
  • Patients with structural heart disease or known diastolic dysfunction or cirrhotic cardiomyopathy
  • Patients who are on vasopressors or inotropes,
  • Patients already receiving renal replacement therapy
  • Patients with known chronic obstructive lung disease or congestive heart failure
  • Patients with serum albumin below 1.5 g/dl
  • Patients in need of surgical intervention
  • Pregnant or lactating women
  • Patients with a previous adverse reaction to human albumin.

Key Trial Info

Start Date :

September 30 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 31 2024

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06076330

Start Date

September 30 2023

End Date

August 31 2024

Last Update

October 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute of Liver & Biliary Sciences (ILBS)

New Delhi, National Capital Territory of Delhi, India, 110070